RADX Independent Test Assessment Program for MPOX Lesion Panel - Coordination Center

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N92022D00014-0-759202300005-1

Grant search

Key facts

  • Disease

    mpox
  • Start & end year

    2023
    2024
  • Known Financial Commitments (USD)

    $153,450
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    STEVEN C SCHRATER
  • Research Location

    United States of America
  • Lead Research Institution

    MASSACHUSETTS GENERAL HOSPITAL
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

  • Mpox Research Priorities

    Pathogen: natural history, transmission and diagnostics

  • Mpox Research Sub Priorities

    Development of equitable, accessible, safe & effective diagnostics (including POC)

Abstract

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxÃ'®) Tech program has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests.